Moderna Stock Soars On ‘Transformational’ Potential Of Its Merck-Tied Cancer Vaccine
Investor's Business DailyModerna’s Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients. Moderna stock soared.
The post Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine appeared first on I…